glp-1 agonist dpp 4 inhibitor receptor agonists or DPP-4 inhibitors: How to guide the clinician? DPP4 Inhibitors vs GLP-1 Agonists
Description
doi:10.1016/S2213-8587(17)30092-X 27
At the same time, patients are still being treated with sulfonylureas, which can actually be harmful to our patients
What the clinical trial numbers do not capture is the real-world experience where many patients on various semaglutide doses report sulfur burps that come and go, particularly in the first few weeks and after dose escalations
Conservative measures like exercise, diet and behavioral modifications are some of the initial ways to lose weight
If youre on the fence about GLP-1s or just want a natural alternative, try our Berberine supplement today
